Sorafenib for advanced-stage hepatocellular carcinoma

Eur J Gastroenterol Hepatol. 2012 Mar;24(3):346-7. doi: 10.1097/MEG.0b013e3283501a2e.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Benzenesulfonates / therapeutic use*
  • Carcinoma, Hepatocellular / drug therapy*
  • Female
  • Humans
  • Liver Neoplasms / drug therapy*
  • Male
  • Pyridines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Pyridines